Sequoia Hospital

Recent papers from Sequoia Hospital

1. Contralateral lower-limb growth after systemic chemotherapy and surgery for high-grade osteosarcoma in children: a retrospective longitudinal MRI studyJournal of Orthopaedic Surgery and Research · 2026
2. Refractory Prepatellar Degloving Injury following Low-Energy Trauma With Predisposing Total Knee Arthroplasty: Incidence and Treatment ExperienceTechniques in Orthopaedics · 2026
3. Combined Epicardial and Endocardial Ablation for Atrial Fibrillation: An Updated Best Practices Guide to Hybrid Convergent ProceduresHeart Rhythm O2 · 2026
4. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) TrialJournal of the American College of Cardiology · 2011
5. Long-term outcome with the automatic implantable cardioverter-defibrillatorJournal of the American College of Cardiology · 1989
6. Freezing nitrogen ethanol composite in treating giant cell tumor of bone: a clinical series of 32 patientsJournal of Orthopaedic Surgery and Research · 2026
7. Prognostic impact of preoperative MRI on core decompression in ARCO stage III osteonecrosis of the femoral head: a retrospective cohort studyJournal of Orthopaedic Surgery and Research · 2026
8. Identifying engagement strategies for Hispanic youth with anxiety: A youth-centered, Design-Thinking approachPLoS ONE · 2025
9. Evaluating Pregnancy Safety During Cardiology TrainingJAMA Cardiology · 2024
10. Ten-Year Follow-Up of Mitral Valve Replacement with the Epic Porcine Valve in a Medicare PopulationThe Annals of Thoracic Surgery · 2024
11. The psychometric properties of the modified fear of falling avoidance behavior questionnaire in Parkinson’s disease and older adultsArchives of Physiotherapy · 2024
12. Abstract 3915: BMS-986442 (AGEN1777), a novel TIGIT/CD96 bispecific antibody, demonstrates superior monotherapy and combination activity versus conventional anti-TIGIT antibodies in preclinical modelsCancer Research · 2024
13. Abstract 1351: Preclinical characterization of BMS-986288, a novel non-fucosylated (NF) anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) Probody® therapeuticCancer Research · 2024
14. Abstract 6892: Murine ex vivo platform: A powerful tool for biomarker assessment and high throughput screening of translationally relevant in vivo tumor models for PD and efficacy studiesCancer Research · 2024
15. Abstract 5177: Ex vivo assessment of cellular mass response predicts clinical efficacy in solid tumorsCancer Research · 2024
16. Early ablation of newly diagnosed paroxysmal atrial fibrillation (NEWPaAF) versus newly diagnosed persistent atrial fibrillation (NEWPeAF): Comparison of patient populations and ablation outcomesJournal of Cardiovascular Electrophysiology · 2024
17. Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of MalignanciesJCO Precision Oncology · 2024
18. Pericarditis prophylactic therapy after sinus node–sparing hybrid ablation for inappropriate sinus tachycardia/postural orthostatic sinus tachycardiaHeart Rhythm O2 · 2024
19. Improving Outcomes in Mechanically Ventilated Adult ICU Patients Following Implementation of the ICU Liberation (ABCDEF) Bundle Across a Large Healthcare SystemCritical Care Explorations · 2024
20. Redo procedures after sinus node sparing hybrid ablation for inappropriate sinus tachycardia/postural orthostatic sinus tachycardiaEP Europace · 2023